_id
69131659ccc777a4e85d8099
Ticker
MHUA
Name
Meihua International Medical Technologies Co Ltd
Exchange
NASDAQ
Address
88 Tongda Road, Yangzhou, China, 225000
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://www.meihuamed.com
Description
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; Class II products, such as disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, etc.; and Class III disposable medical devices, such as disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. It also offers disposable plastic baby bottles, NB/PSN rubber covers and 8.2mL folded spoons for tools and containers, etc.; Class II 6866 medical polymer materials and products, including transfusion equipment and pipelines, endotracheal intubation for respiratory anesthesia or ventilation; and medical x-ray films and multi-functional self-extracting X-ray film machines. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China.
Last Close
2.05
Volume
-
Current Price
2.65
Change
-0.38
Last Updated
2026-01-05T10:28:57.025Z
Image
data:image/webp;base64,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
Ipo Date
2022-02-16T00:00:00.000Z
Market Cap
425433024
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.296
Sentiment Sources
1
Current Quarter
2025-06-30
Revenue
37981620
Cost Of Revenue
25369068
Gross Profit
12612552
Operating Expenses
9373446
Operating Income
3239106
Interest Expense
245538
Pretax Income
3802814
Net Income
3145022
Eps
9.857612562491184
Dividends Per Share
-
Shares Outstanding
55904468
Income Tax Expense
657792
EBITDA
3514480
Operating Margin
8.528088059435063
Total Other Income Expense Net
563708
Cash
15548394
Short Term Investments
-
Receivables
117666033
Inventories
1100564
Total Current Assets
146340878
Property Plant Equipment
7775330
Total Assets
190584205
Payables
11348895
Short Term Debt
11446759
Long Term Debt
-
Total Liabilities
25639049
Equity
164945156
Bs_currency_symbol
USD
Depreciation
275374
Change In Working Capital
-9940480
Cash From Operations
-19804654
Capital Expenditures
10242
Cash From Investing
12177250
Cash From Financing
6618316
Net Change In Cash
-386490
Cf_currency_symbol
-
PE
0.2455
PB
0.005125759801033502
ROE
1.90670770592378
ROA
1.6502007603410787
FCF
-19814896
Fcf Percent
-0.5216969681651283
Piotroski FScore
2
Health Score
51
Deep Value Investing Score
8
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.8
Garp Investing Score
7
Growth Investing Score
5.5
Momentum Investing Score
8
Net Net Investing Score
2.5
Quality Investing Score
5
Value Investing Score
8
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
37981620
Quarters > 0 > income Statement > cost Of Revenue
25369068
Quarters > 0 > income Statement > gross Profit
12612552
Quarters > 0 > income Statement > operating Expenses
9373446
Quarters > 0 > income Statement > operating Income
3239106
Quarters > 0 > income Statement > interest Expense
245538
Quarters > 0 > income Statement > pretax Income
3802814
Quarters > 0 > income Statement > net Income
3145022
Quarters > 0 > income Statement > eps
9.857612562491184
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
319045
Quarters > 0 > income Statement > income Tax Expense
657792
Quarters > 0 > income Statement > EBITDA
3514480
Quarters > 0 > income Statement > operating Margin
8.528088059435063
Quarters > 0 > income Statement > total Other Income Expense Net
563708
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
15548394
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
117666033
Quarters > 0 > balance Sheet > inventories
1100564
Quarters > 0 > balance Sheet > total Current Assets
146340878
Quarters > 0 > balance Sheet > property Plant Equipment
7775330
Quarters > 0 > balance Sheet > total Assets
190584205
Quarters > 0 > balance Sheet > payables
11348895
Quarters > 0 > balance Sheet > short Term Debt
11446759
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
25639049
Quarters > 0 > balance Sheet > equity
164945156
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
3145022
Quarters > 0 > cash Flow > depreciation
275374
Quarters > 0 > cash Flow > change In Working Capital
-9940480
Quarters > 0 > cash Flow > cash From Operations
-19804654
Quarters > 0 > cash Flow > capital Expenditures
10242
Quarters > 0 > cash Flow > cash From Investing
12177250
Quarters > 0 > cash Flow > cash From Financing
6618316
Quarters > 0 > cash Flow > net Change In Cash
-386490
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
9.857612562491184
Quarters > 0 > ratios > PB
0.005125759801033502
Quarters > 0 > ratios > ROE
1.90670770592378
Quarters > 0 > ratios > ROA
1.6502007603410787
Quarters > 0 > ratios > FCF
-19814896
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.5216969681651283
Quarters > 0 > health Score
51
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
18990810
Quarters > 1 > income Statement > cost Of Revenue
12684534
Quarters > 1 > income Statement > gross Profit
6306276
Quarters > 1 > income Statement > operating Expenses
4686723
Quarters > 1 > income Statement > operating Income
1619553
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
1901407
Quarters > 1 > income Statement > net Income
1572511
Quarters > 1 > income Statement > eps
0.04928811224810268
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
31904468
Quarters > 1 > income Statement > income Tax Expense
328896
Quarters > 1 > income Statement > EBITDA
1757240
Quarters > 1 > income Statement > operating Margin
8.528088059435063
Quarters > 1 > income Statement > total Other Income Expense Net
281854
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
15548394
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
117666033
Quarters > 1 > balance Sheet > inventories
1100564
Quarters > 1 > balance Sheet > total Current Assets
146340878
Quarters > 1 > balance Sheet > property Plant Equipment
7775330
Quarters > 1 > balance Sheet > total Assets
190584205
Quarters > 1 > balance Sheet > payables
11348895
Quarters > 1 > balance Sheet > short Term Debt
11446759
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
25639049
Quarters > 1 > balance Sheet > equity
164945156
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
1572511
Quarters > 1 > cash Flow > depreciation
137687
Quarters > 1 > cash Flow > change In Working Capital
-4970240
Quarters > 1 > cash Flow > cash From Operations
-4951164
Quarters > 1 > cash Flow > capital Expenditures
5121
Quarters > 1 > cash Flow > cash From Investing
3044313
Quarters > 1 > cash Flow > cash From Financing
1654579
Quarters > 1 > cash Flow > net Change In Cash
-1201683
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.04928811224810268
Quarters > 1 > ratios > PB
0.5125754659930722
Quarters > 1 > ratios > ROE
0.95335385296189
Quarters > 1 > ratios > ROA
0.8251003801705393
Quarters > 1 > ratios > FCF
-4956285
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.26098333878333785
Quarters > 1 > health Score
50
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
51565944
Quarters > 2 > income Statement > cost Of Revenue
33538528
Quarters > 2 > income Statement > gross Profit
18027416
Quarters > 2 > income Statement > operating Expenses
9607513
Quarters > 2 > income Statement > operating Income
8419903
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
7740783
Quarters > 2 > income Statement > net Income
6127000
Quarters > 2 > income Statement > eps
20.79197505098734
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
294681
Quarters > 2 > income Statement > income Tax Expense
1613801
Quarters > 2 > income Statement > EBITDA
9397426
Quarters > 2 > income Statement > operating Margin
16.32841822889929
Quarters > 2 > income Statement > total Other Income Expense Net
-679120
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
15960057
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
114999307
Quarters > 2 > balance Sheet > inventories
1409639
Quarters > 2 > balance Sheet > total Current Assets
143438322
Quarters > 2 > balance Sheet > property Plant Equipment
7886579
Quarters > 2 > balance Sheet > total Assets
186239116
Quarters > 2 > balance Sheet > payables
15475673
Quarters > 2 > balance Sheet > short Term Debt
7945966
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
27263569
Quarters > 2 > balance Sheet > equity
158975547
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
6127000
Quarters > 2 > cash Flow > depreciation
279236
Quarters > 2 > cash Flow > change In Working Capital
5100924
Quarters > 2 > cash Flow > cash From Operations
13621006
Quarters > 2 > cash Flow > capital Expenditures
123128
Quarters > 2 > cash Flow > cash From Investing
-14996168
Quarters > 2 > cash Flow > cash From Financing
79430
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
20.79197505098734
Quarters > 2 > ratios > PB
0.0049121054447449075
Quarters > 2 > ratios > ROE
3.8540518435832145
Quarters > 2 > ratios > ROA
3.2898566808059804
Quarters > 2 > ratios > FCF
13497878
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.2617595442449381
Quarters > 2 > health Score
72
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
25782972
Quarters > 3 > income Statement > cost Of Revenue
16747338
Quarters > 3 > income Statement > gross Profit
9035633
Quarters > 3 > income Statement > operating Expenses
4825682
Quarters > 3 > income Statement > operating Income
4209952
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
3870392
Quarters > 3 > income Statement > net Income
3063500
Quarters > 3 > income Statement > eps
0.10319237494076165
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
29687271
Quarters > 3 > income Statement > income Tax Expense
806900
Quarters > 3 > income Statement > EBITDA
4349570
Quarters > 3 > income Statement > operating Margin
16.328420168163703
Quarters > 3 > income Statement > total Other Income Expense Net
-339560
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
15960057
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
97954138
Quarters > 3 > balance Sheet > inventories
1409639
Quarters > 3 > balance Sheet > total Current Assets
143438322
Quarters > 3 > balance Sheet > property Plant Equipment
7886579
Quarters > 3 > balance Sheet > total Assets
186239116
Quarters > 3 > balance Sheet > payables
15475673
Quarters > 3 > balance Sheet > short Term Debt
7945966
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
27263569
Quarters > 3 > balance Sheet > equity
158975547
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
3063500
Quarters > 3 > cash Flow > depreciation
139618
Quarters > 3 > cash Flow > change In Working Capital
2550462
Quarters > 3 > cash Flow > cash From Operations
6810503
Quarters > 3 > cash Flow > capital Expenditures
61564
Quarters > 3 > cash Flow > cash From Investing
-7498084
Quarters > 3 > cash Flow > cash From Financing
39715
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.10319237494076165
Quarters > 3 > ratios > PB
0.494863956341663
Quarters > 3 > ratios > ROE
1.9270259217916073
Quarters > 3 > ratios > ROA
1.6449283404029902
Quarters > 3 > ratios > FCF
6748939
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.2617595442449381
Quarters > 3 > health Score
72
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
96909642
Annuals > 0 > income Statement > cost Of Revenue
63609840
Annuals > 0 > income Statement > gross Profit
33299802
Annuals > 0 > income Statement > operating Expenses
18987887
Annuals > 0 > income Statement > operating Income
14311915
Annuals > 0 > income Statement > interest Expense
1506700
Annuals > 0 > income Statement > pretax Income
13626131
Annuals > 0 > income Statement > net Income
10843589
Annuals > 0 > income Statement > eps
39.61605965285313
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
273717
Annuals > 0 > income Statement > income Tax Expense
2788824
Annuals > 0 > income Statement > EBITDA
15703865
Annuals > 0 > income Statement > operating Margin
14.768308606485203
Annuals > 0 > income Statement > total Other Income Expense Net
-685784
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
15960057
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
114999307
Annuals > 0 > balance Sheet > inventories
1409639
Annuals > 0 > balance Sheet > total Current Assets
143438322
Annuals > 0 > balance Sheet > property Plant Equipment
7886579
Annuals > 0 > balance Sheet > total Assets
186239116
Annuals > 0 > balance Sheet > payables
15475673
Annuals > 0 > balance Sheet > short Term Debt
7945966
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
27263569
Annuals > 0 > balance Sheet > equity
158975547
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
10837307
Annuals > 0 > cash Flow > depreciation
571035
Annuals > 0 > cash Flow > change In Working Capital
-27971
Annuals > 0 > cash Flow > cash From Operations
14636805
Annuals > 0 > cash Flow > capital Expenditures
133550
Annuals > 0 > cash Flow > cash From Investing
-20421028
Annuals > 0 > cash Flow > cash From Financing
6213831
Annuals > 0 > cash Flow > net Change In Cash
362074
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
39.61605965285313
Annuals > 0 > ratios > PB
0.0035295984859860237
Annuals > 0 > ratios > ROE
6.820916301045972
Annuals > 0 > ratios > ROA
5.822401455127181
Annuals > 0 > ratios > FCF
14503255
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.14965750260433322
Annuals > 0 > health Score
67
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
97098915
Annuals > 1 > income Statement > cost Of Revenue
64003913
Annuals > 1 > income Statement > gross Profit
33095000
Annuals > 1 > income Statement > operating Expenses
18420064
Annuals > 1 > income Statement > operating Income
14674938
Annuals > 1 > income Statement > interest Expense
250781
Annuals > 1 > income Statement > pretax Income
15048774
Annuals > 1 > income Statement > net Income
11625417
Annuals > 1 > income Statement > eps
48.560639097744364
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
239400
Annuals > 1 > income Statement > income Tax Expense
3457733
Annuals > 1 > income Statement > EBITDA
15770550
Annuals > 1 > income Statement > operating Margin
15.113390298954421
Annuals > 1 > income Statement > total Other Income Expense Net
373836
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
16926878
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
99480344
Annuals > 1 > balance Sheet > inventories
1617225
Annuals > 1 > balance Sheet > total Current Assets
132237053
Annuals > 1 > balance Sheet > property Plant Equipment
8838055
Annuals > 1 > balance Sheet > total Assets
171915272
Annuals > 1 > balance Sheet > payables
15822029
Annuals > 1 > balance Sheet > short Term Debt
7326542
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
25077450
Annuals > 1 > balance Sheet > equity
146331840
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
11591041
Annuals > 1 > cash Flow > depreciation
470993
Annuals > 1 > cash Flow > change In Working Capital
-11600397
Annuals > 1 > cash Flow > cash From Operations
2275750
Annuals > 1 > cash Flow > capital Expenditures
4686582
Annuals > 1 > cash Flow > cash From Investing
-12458698
Annuals > 1 > cash Flow > cash From Financing
706125
Annuals > 1 > cash Flow > net Change In Cash
-9809822
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
48.560639097744364
Annuals > 1 > ratios > PB
0.0033538155469103647
Annuals > 1 > ratios > ROE
7.944557384093579
Annuals > 1 > ratios > ROA
6.7622945098210945
Annuals > 1 > ratios > FCF
-2410832
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
-0.02482861935171984
Annuals > 1 > health Score
56
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
103346341
Annuals > 2 > income Statement > cost Of Revenue
65247864
Annuals > 2 > income Statement > gross Profit
38098477
Annuals > 2 > income Statement > operating Expenses
22540979
Annuals > 2 > income Statement > operating Income
10801962
Annuals > 2 > income Statement > interest Expense
194667
Annuals > 2 > income Statement > pretax Income
10891247
Annuals > 2 > income Statement > net Income
6242969
Annuals > 2 > income Statement > eps
26.666705109969204
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
234111
Annuals > 2 > income Statement > income Tax Expense
4713543
Annuals > 2 > income Statement > EBITDA
11649375
Annuals > 2 > income Statement > operating Margin
10.452195883742029
Annuals > 2 > income Statement > total Other Income Expense Net
89285
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
26736700
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
91031638
Annuals > 2 > balance Sheet > inventories
1122038
Annuals > 2 > balance Sheet > total Current Assets
135319155
Annuals > 2 > balance Sheet > property Plant Equipment
8758047
Annuals > 2 > balance Sheet > total Assets
163577579
Annuals > 2 > balance Sheet > payables
16096165
Annuals > 2 > balance Sheet > short Term Debt
6089428
Annuals > 2 > balance Sheet > long Term Debt
724932
Annuals > 2 > balance Sheet > total Liabilities
24898499
Annuals > 2 > balance Sheet > equity
138122937
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
6177704
Annuals > 2 > cash Flow > depreciation
563461
Annuals > 2 > cash Flow > change In Working Capital
-20411330
Annuals > 2 > cash Flow > cash From Operations
-9163038
Annuals > 2 > cash Flow > capital Expenditures
2698729
Annuals > 2 > cash Flow > cash From Investing
-8620292
Annuals > 2 > cash Flow > cash From Financing
37245500
Annuals > 2 > cash Flow > net Change In Cash
18587424
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
26.666705109969204
Annuals > 2 > ratios > PB
0.0034746404936350284
Annuals > 2 > ratios > ROE
4.5198640686303975
Annuals > 2 > ratios > ROA
3.816518766303541
Annuals > 2 > ratios > FCF
-11861767
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.11477684536504297
Annuals > 2 > health Score
48
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
104037710
Annuals > 3 > income Statement > cost Of Revenue
64232469
Annuals > 3 > income Statement > gross Profit
39805241
Annuals > 3 > income Statement > operating Expenses
14502620
Annuals > 3 > income Statement > operating Income
25302621
Annuals > 3 > income Statement > interest Expense
180744
Annuals > 3 > income Statement > pretax Income
25269708
Annuals > 3 > income Statement > net Income
19991246
Annuals > 3 > income Statement > eps
0.9995623
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
20000000
Annuals > 3 > income Statement > income Tax Expense
5278462
Annuals > 3 > income Statement > EBITDA
25898512
Annuals > 3 > income Statement > operating Margin
24.32062470425387
Annuals > 3 > income Statement > total Other Income Expense Net
-32913
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
8149276
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
86481142
Annuals > 3 > balance Sheet > inventories
1251393
Annuals > 3 > balance Sheet > total Current Assets
97276350
Annuals > 3 > balance Sheet > property Plant Equipment
7477744
Annuals > 3 > balance Sheet > total Assets
136857381
Annuals > 3 > balance Sheet > payables
20981041
Annuals > 3 > balance Sheet > short Term Debt
5178420
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
30047112
Annuals > 3 > balance Sheet > equity
106810269
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
19991246
Annuals > 3 > cash Flow > depreciation
622473
Annuals > 3 > cash Flow > change In Working Capital
-20683663
Annuals > 3 > cash Flow > cash From Operations
-54663
Annuals > 3 > cash Flow > capital Expenditures
850231
Annuals > 3 > cash Flow > cash From Investing
-833817
Annuals > 3 > cash Flow > cash From Financing
1860234
Annuals > 3 > cash Flow > net Change In Cash
961942
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.9995623
Annuals > 3 > ratios > PB
0.3838582224710996
Annuals > 3 > ratios > ROE
18.7165954988841
Annuals > 3 > ratios > ROA
14.60735683667657
Annuals > 3 > ratios > FCF
-904894
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.00869775007542938
Annuals > 3 > health Score
72
Valuation > metrics > PE
0.2455
Valuation > metrics > PB
0.005125759801033502
Valuation > final Score
90
Valuation > verdict
98.5% Undervalued
Profitability > metrics > ROE
1.90670770592378
Profitability > metrics > ROA
2.149106963810891
Profitability > metrics > Net Margin
0.08280378772680048
Profitability > final Score
23
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.15543984207696285
Risk > metrics > Interest Coverage
13.1918725411138
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
6.419683243130467
Liquidity > metrics > Quick Ratio
6.371403689492743
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
100
Prev Valuations > 2
90
Prev Profitabilities > 0
18
Prev Profitabilities > 1
38
Prev Profitabilities > 2
28
Prev Risks > 0
100
Prev Risks > 1
80
Prev Risks > 2
95
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:12:29.017Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-18
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.1
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-04-25
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.19
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.19
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-09-20
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.17
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.17
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-03-31
Earnings History > 3 > report Date
2023-04-14
Earnings History > 3 > date
2023-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0.27
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0.27
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-09-30
Earnings History > 4 > report Date
2022-11-14
Earnings History > 4 > date
2022-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.29
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0.29
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-06-30
Earnings History > 5 > report Date
2021-08-31
Earnings History > 5 > date
2021-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.83
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0.83
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-09-30
Earnings History > 6 > report Date
2020-12-31
Earnings History > 6 > date
2020-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.51
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0.51
Earnings History > 6 > surprise Percent
-
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; Class II products, such as disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, etc.; and Class III disposable medical devices, such as disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. It also offers disposable plastic baby bottles, NB/PSN rubber covers and 8.2mL folded spoons for tools and containers, etc.; Class II 6866 medical polymer materials and products, including transfusion equipment and pipelines, endotracheal intubation for respiratory anesthesia or ventilation; and medical x-ray films and multi-functional self-extracting X-ray film machines. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAug Intraday: Will MHUA benefit from green energy policies - Analyst Downgrade & Free Verified High Yield Trade Plans baoquankhu1.vn
Read more →What consensus target says about MYO stock - July 2025 Chart Watch & Low Risk Entry Point Guides ulpravda.ru
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.51% of the total shares of Meihua International Medical Technologies Co Ltd
1.
UBS Group AG(0.2935%)
since
2025/06/30
2.
Renaissance Technologies Corp(0.0755%)
since
2025/06/30
3.
TWO SIGMA SECURITIES, LLC(0.0509%)
since
2025/06/30
4.
Geode Capital Management, LLC(0.0451%)
since
2025/06/30
5.
Fidelity Nasdaq Composite Index(0.0451%)
since
2025/07/31
6.
Morgan Stanley - Brokerage Accounts(0%)
since
2025/06/30
7.
Jane Street Group LLC(0%)
since
2025/06/30
8.
Two Sigma Investments LLC(0%)
since
2025/06/30
9.
Virtu Financial LLC(0%)
since
2025/03/31
10.
XTX Topco Ltd(0%)
since
2025/06/30
11.
Citadel Advisors Llc(0%)
since
2025/06/30
12.
HRT FINANCIAL LLC(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
0.1
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.